(Q35225125)

7 August 2017

0 references

Hepatotoxicity due to tocilizumab and anakinra in rheumatoid arthritis: two case reports (English)

1 reference

7 August 2017

1 reference

1 reference

1 reference

1 reference

Mahmud Mahamid

1

1 reference

7 August 2017

Kalman Paz

series ordinal

2

1 reference

7 August 2017

Mader Reuven

series ordinal

3

1 reference

7 August 2017

Rifaat Safadi

series ordinal

4

1 reference

7 August 2017

language of work or name

English

0 references

publication date

7 September 2011

1 reference

International Journal of General Medicine

7 August 2017

published in

1 reference

7 August 2017

volume

4

1 reference

7 August 2017

page(s)

657-660

1 reference

Creative Commons Attribution-NonCommercial 3.0 Unported

7 August 2017

copyright license

start time

1 September 2011

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Anakinra for rheumatoid arthritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3177591

Liver failure after major hepatic resection

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3177591

Systematic review: comparative effectiveness and harms of disease-modifying medications for rheumatoid arthritis

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3177591

Safety of extended treatment with anakinra in patients with rheumatoid arthritis

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3177591

Combination therapy with etanercept and anakinra in the treatment of patients with rheumatoid arthritis who have been treated unsuccessfully with methotrexate

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3177591

Plasminogen activator inhibitor-1, inflammation, obesity, insulin resistance and vascular risk

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3177591

What are the risks of biologic therapy in rheumatoid arthritis? An update on safety.

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3177591

Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice.

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3177591

The role of IL-10 in crossregulation of TH1 and TH2 responses

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3177591

Activation of interleukin-6-induced glycoprotein 130/signal transducer and activator of transcription 3 pathway in mesenchymal stem cells enhances hepatic differentiation, proliferation, and liver regeneration

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3177591

Role of IL-6 trans-signaling in CCl₄induced liver damage

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3177591

The effects of treatment with interleukin-1 receptor antagonist on the inflamed synovial membrane in rheumatoid arthritis

26 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21941451

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.2147/IJGM.S23920

1 reference

7 August 2017

1 reference

7 August 2017

1 reference